These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28073423)

  • 41. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
    Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
    Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ANXA2
    Xing X; Yuan H; Sun Y; Ke K; Dong X; Chen H; Liu X; Zhao B; Huang A
    J Proteomics; 2019 May; 200():111-122. PubMed ID: 30951906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
    Masuda T; Miyoshi E
    Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags.
    Megger DA; Rosowski K; Ahrens M; Bracht T; Eisenacher M; Schlaak JF; Weber F; Hoffmann AC; Meyer HE; Baba HA; Sitek B
    Biomarkers; 2017 Mar; 22(2):113-122. PubMed ID: 27467182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential plant proteome analysis by isobaric tags for relative and absolute quantitation (iTRAQ).
    Martínez-Esteso MJ; Casado-Vela J; Sellés-Marchart S; Pedreño MA; Bru-Martínez R
    Methods Mol Biol; 2014; 1072():155-69. PubMed ID: 24136521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database.
    Yan J; Fang X; Feng Y; Cui X; Li F; Luo W; Ma X; Liang J; Feng J
    Ann Hepatol; 2022; 27(3):100681. PubMed ID: 35124283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics for the early detection and treatment of hepatocellular carcinoma.
    Feng JT; Shang S; Beretta L
    Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative proteomics for identification of cancer biomarkers.
    Chaerkady R; Pandey A
    Proteomics Clin Appl; 2007 Sep; 1(9):1080-9. PubMed ID: 21136759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection.
    Liu H; Chen H; Wu X; Sun Y; Wang Y; Zeng Y; Chen G; Liu X; Xing X; Zhao B; Liu J
    Cancer Manag Res; 2019; 11():2935-2946. PubMed ID: 31114342
    [No Abstract]   [Full Text] [Related]  

  • 54. Sample Preparation Approaches for iTRAQ Labeling and Quantitative Proteomic Analyses in Systems Biology.
    Spanos C; Moore JB
    Methods Mol Biol; 2016; 1394():15-24. PubMed ID: 26700038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network.
    Shen C; Yu Y; Li H; Yan G; Liu M; Shen H; Yang P
    Proteomics; 2012 Jun; 12(12):1917-27. PubMed ID: 22623320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
    Lin Q; Peng S; Yang Y
    Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.
    Li X; Jiang J; Zhao X; Zhao Y; Cao Q; Zhao Q; Han H; Wang J; Yu Z; Peng B; Ying W; Qian X
    Oncotarget; 2016 Apr; 7(16):22031-49. PubMed ID: 27014972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mass defect-based pseudo-isobaric dimethyl labeling for proteome quantification.
    Zhou Y; Shan Y; Wu Q; Zhang S; Zhang L; Zhang Y
    Anal Chem; 2013 Nov; 85(22):10658-63. PubMed ID: 24180428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel quantitative proteomics workflow by isobaric terminal labeling.
    Yang SJ; Nie AY; Zhang L; Yan GQ; Yao J; Xie LQ; Lu HJ; Yang PY
    J Proteomics; 2012 Oct; 75(18):5797-806. PubMed ID: 22813877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3 h.
    Du C; Weng Y; Lou J; Zeng G; Liu X; Jin H; Lin S; Tang L
    Int J Mol Med; 2019 May; 43(5):1991-2004. PubMed ID: 30896787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.